HER2 Support Group Forums - View Single Post - CDK inhibitors as potential therapeutics for ER+/ and/or Her2+ bc

Hopeful · 12-08-2009, 02:30 PM

The one they reference in the editorial is PD 0332991. Pfizer is currently testing it with letrozole, but only in ER+ Her2- patients: http://clinicaltrials.gov/show/NCT00721409

Here is a link to the definiton of the drug: http://www.cancer.gov/drugdictionary/?CdrID=454586

Hopeful

12-08-2009, 02:30 PM	#3
Hopeful Senior Member Join Date: Aug 2006 Posts: 3,380	Re: CDK inhibitors as potential therapeutics for ER+/ and/or Her2+ bc The one they reference in the editorial is PD 0332991. Pfizer is currently testing it with letrozole, but only in ER+ Her2- patients: http://clinicaltrials.gov/show/NCT00721409 Here is a link to the definiton of the drug: http://www.cancer.gov/drugdictionary/?CdrID=454586 Hopeful